key: cord-0958237-n4vch3m2
authors: Tuckerman, Jane; Lee, Lai‐Yang; Wurzel, Danielle; Tosif, Shidan; Clifford, Vanessa; McMinn, Alissa; O'Donaghue, Kate; Rautenbacher, Karin; Licciardi, Paul V; Toh, Ryan; Daley, Andrew; Crawford, Nigel W
title: Seroprevalence of SARS‐CoV‐2 antibodies in health‐care workers at a tertiary paediatric hospital
date: 2021-07-03
journal: J Paediatr Child Health
DOI: 10.1111/jpc.15585
sha: 48b7666db73cc8ffb8c9e4e5454c5911b6110d79
doc_id: 958237
cord_uid: n4vch3m2

nan

Despite the Australian Government advocating for serosurveys as part of the national COVID-19 Surveillance Plan, 4 few have been undertaken. 5, 6 A meta-analysis from several countries indicated a seroprevalence of 8.7% (range 0-45.3%) in HCWs. 7 There is likely to be less workplace SARS-CoV-2 exposure in paediatric hospitals due to the lower incidence of paediatric hospitalisations 8, 9 ; however, there are few published surveys in this setting 10 and none amongst paediatric HCWs in Australia.

The aim of this study was to investigate the presence of SARS-CoV-2 antibodies in HCWs employed at the Royal Children's Hospital (RCH), Melbourne, Australia.

All RCH HCWs were invited to participate between 21 and 30 October 2020. Participants reported demographics, risk factors and previous SARS-CoV-2 testing via a web-based REDCap questionnaire. Serum samples were analysed by the DiaSorin (Diasorin S.p.A., Saluggia (VC) -Italy) LIAISON SARS-CoV-2 S1/ S2 IgG assay. Samples with positive or equivocal results were also tested by the Victorian Infectious Diseases Reference Laboratory (Table 2) .

Of the three HCWs who returned positive SARS-CoV-2 results, two resided in COVID-19 'hot spot' postcodes during Victoria's second wave. One HCW, diagnosed with COVID-19 20 days prior, had equivocal results by the DiaSorin assay on both initial and repeat testing while their colleague, classified as a close contact during contact tracing, returned positive DiaSorin serology results. The other two HCWs, who returned positive results, reported additional risk factors (Table 2) .

Our study in a paediatric hospital identified a very low rate of SARS-CoV-2 antibodies in HCWs; 2.2% using the DiaSorin assay. It is interesting to note that serology testing with alternative assays (including two in-house) was negative, including for the staff member with confirmed COVID-19. The difference in results likely reflects the limitations of each assay's specificity and sensitivity, particularly in the context of a low prevalence setting. The DiaSorin assay measures antibodies to S1 and S2 and as the S2 subunit is a more conserved coronavirus region, this may result in antibody cross reactivity. 12, 13 Although there are no published paediatric Australian HCW serosurveys, one tertiary Victorian public health network 10 reports a seroprevalence of 2.17%. Studies from Denmark, Germany and the USA report SARS-CoV-2 seroprevalence in HCWs in the range of 2-9%, 7,14-17 which is higher compared to the general community and in HCWs working in dedicated COVID-19 areas. 14 The few paediatric health-care setting serosurveys reported from high prevalence settings (India, Spain and Italy) have found a prevalence of 4-16.8% in paediatric HCWs. [18] [19] [20] This study identified a low percentage of seropositive HCWs despite community transmission, which reasonably reflects the low prevalence of symptomatic paediatric cases and potentially the lower transmissibility of COVID-19 in children. Our findings support the use of infection control procedures, including convenient access to onsite screening of visitors, COVID-19 testing and a dedicated COVID-19 response team.

Risk of COVID-19 among front-line health-care workers and the general community: A prospective cohort study

Victorian Coronavirus (COVID-19) Data. Department of Health and Human Services

Victorian Healthcare Worker (Clinical and Non-Clinical) Coronavirus (COVID-19) Data. Department of Health and Human Services, State Government of Victoria

Australian National Disease Surveillance Plan for COVID-19. Canberra: Australian Government Department of Health

Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020

A dual-antigen enzyme-linked immunosorbent assay allows the assessment of severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in a lowtransmission setting

Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: A systematic review and meta-analysis

Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratoryconfirmed COVID-19 -COVID-NET, 14 states

COVID-19 in health-care workers: Testing and outcomes at a Victorian tertiary children's hospital

SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria

A serological assay to detect SARS-CoV-2 seroconversion in humans

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

Differences in performance characteristics among four high-throughput assays for the detection of antibodies against SARS-CoV-2 using a common set of patient samples

Risk of COVID-19 in health-care workers in Denmark: An observational cohort study

Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City area

Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals

Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for COVID-19 patients

Seroprevalence to SARS-CoV-2 among healthcare workers in an exclusive pediatric hospital

Seroprevalence of SARS-CoV-2 among pediatric healthcare workers in Spain

Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave